Health
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345) – Business Wire
Moderna receives FDA Fast Track designation for Respiratory Syncytial Virus (RSV) vaccine (mRNA-1345).
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for mRNA-1345,…
Continue Reading
-
Noosa News12 hours agoNoosa Hospital unveils cutting-edge breast cancer treatment
-
Noosa News9 hours agoPreserving Australia’s oldest commercial grape vines in winemaking Barossa Valley
-
General11 hours agoUS independence day? Poll shows Australians’ radical shift over Trump, economy
-
General10 hours ago‘Single biggest investment’ in WNBL sees players’ minimum wages increase by 104 per cent